Prot# 20070664: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed Dose Study of AMG 223 in Subjects with Chronic Kidney Disease on Hemodialysis with Hyperphosphatemia

Project: Research project

Project Details

StatusFinished
Effective start/end date5/12/08 → 5/12/11

Funding

  • Fresenius Medical Care North America (20070664 // 20070664)
  • Amgen, Inc. (20070664 // 20070664)